These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 22573283)
1. Which cholinesterase inhibitor is the safest for the heart in elderly patients with Alzheimer's disease? Isik AT; Bozoglu E; Yay A; Soysal P; Ateskan U Am J Alzheimers Dis Other Demen; 2012 May; 27(3):171-4. PubMed ID: 22573283 [TBL] [Abstract][Full Text] [Related]
2. BCHE and CYP2D6 genetic variation in Alzheimer's disease patients treated with cholinesterase inhibitors. Chianella C; Gragnaniello D; Maisano Delser P; Visentini MF; Sette E; Tola MR; Barbujani G; Fuselli S Eur J Clin Pharmacol; 2011 Nov; 67(11):1147-57. PubMed ID: 21630031 [TBL] [Abstract][Full Text] [Related]
3. A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease. Takeda A; Loveman E; Clegg A; Kirby J; Picot J; Payne E; Green C Int J Geriatr Psychiatry; 2006 Jan; 21(1):17-28. PubMed ID: 16323253 [TBL] [Abstract][Full Text] [Related]
4. Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine. Rodda J; Morgan S; Walker Z Int Psychogeriatr; 2009 Oct; 21(5):813-24. PubMed ID: 19538824 [TBL] [Abstract][Full Text] [Related]
5. The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease. Thompson S; Lanctôt KL; Herrmann N Expert Opin Drug Saf; 2004 Sep; 3(5):425-40. PubMed ID: 15335298 [TBL] [Abstract][Full Text] [Related]
6. Cardiac safety of donepezil in elderly patients with Alzheimer disease. Isik AT; Yildiz GB; Bozoglu E; Yay A; Aydemir E Intern Med; 2012; 51(6):575-8. PubMed ID: 22449664 [TBL] [Abstract][Full Text] [Related]
7. Treatment of Alzheimer's disease in the long-term-care setting. Smith DA Am J Health Syst Pharm; 2009 May; 66(10):899-907. PubMed ID: 19420308 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis. Tan CC; Yu JT; Wang HF; Tan MS; Meng XF; Wang C; Jiang T; Zhu XC; Tan L J Alzheimers Dis; 2014; 41(2):615-31. PubMed ID: 24662102 [TBL] [Abstract][Full Text] [Related]
11. Safety and tolerability of donepezil, rivastigmine and galantamine for patients with Alzheimer's disease: systematic review of the 'real-world' evidence. Lockhart IA; Mitchell SA; Kelly S Dement Geriatr Cogn Disord; 2009; 28(5):389-403. PubMed ID: 19893314 [TBL] [Abstract][Full Text] [Related]
12. Effects of donepezil, galantamine and rivastigmine in 938 Italian patients with Alzheimer's disease: a prospective, observational study. Santoro A; Siviero P; Minicuci N; Bellavista E; Mishto M; Olivieri F; Marchegiani F; Chiamenti AM; Benussi L; Ghidoni R; Nacmias B; Bagnoli S; Ginestroni A; Scarpino O; Feraco E; Gianni W; Cruciani G; Paganelli R; Di Iorio A; Scognamiglio M; Grimaldi LM; Gabelli C; Sorbi S; Binetti G; Crepaldi G; Franceschi C CNS Drugs; 2010 Feb; 24(2):163-76. PubMed ID: 20088621 [TBL] [Abstract][Full Text] [Related]
13. Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer's disease. Mucha L; Shaohung S; Cuffel B; McRae T; Mark TL; Del Valle M J Manag Care Pharm; 2008 Jun; 14(5):451-61. PubMed ID: 18597574 [TBL] [Abstract][Full Text] [Related]
14. Bradycardia due to cholinesterase inhibitors: identify adverse effects and take them into account. Prescrire Int; 2011 Apr; 20(115):95. PubMed ID: 21648211 [TBL] [Abstract][Full Text] [Related]
15. Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease. Cooke JR; Loredo JS; Liu L; Marler M; Corey-Bloom J; Fiorentino L; Harrison T; Ancoli-Israel S Drugs Aging; 2006; 23(6):503-11. PubMed ID: 16872233 [TBL] [Abstract][Full Text] [Related]
17. Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathology. Touchon J; Bergman H; Bullock R; Rapatz G; Nagel J; Lane R Curr Med Res Opin; 2006 Jan; 22(1):49-59. PubMed ID: 16393430 [TBL] [Abstract][Full Text] [Related]
19. Metaanalysis of randomized trials of the efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer disease. Ritchie CW; Ames D; Clayton T; Lai R Am J Geriatr Psychiatry; 2004; 12(4):358-69. PubMed ID: 15249273 [TBL] [Abstract][Full Text] [Related]
20. [Retrospective comparative analysis of antidementia medication persistence patterns in Spanish Alzheimer's disease patients treated with donepezil, rivastigmine, galantamine and memantine]. Sicras-Mainar A; Vergara J; Leon-Colombo T; Febrer L; Rejas-Gutierrez J Rev Neurol; 2006 Oct 16-31; 43(8):449-53. PubMed ID: 17033976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]